Investing to become financially independent
Investing to become financially independent
Investors seeking safety in dividend stocks should look beyond yield and consider dividend growth and the payout ratio. Historical data shows that companies with growing dividends significantly outperform those that pay fixed dividends or no dividends at all.
Why are growing dividends magical? Read More »
Find out why Coca-Cola, with its billions of bottles sold daily, represents an attractive investment opportunity according to Warren Buffett's criteria. Between its stable dividend growth over several consecutive years and its defensive stance against currency fluctuations, the company offers attractive financial prospects for investors.
Discover our detailed analysis of Becton Dickinson (BDX), the US leader in medical devices with a worldwide presence and over 50 years of consecutive dividend increases. An impressive defensive stock that has significantly outperformed the S&P 500, combining stable growth and low volatility for investors.
Find out why Enbridge, the Canadian oil and gas transmission giant, has been offering attractive long-term yields and growing dividends for 16 years. Despite its attractive dollar diversification benefits and low volatility, the high payout ratio of 67.30% currently prompts caution.
Enbridge (Toronto:ENB.TO) Read More »
The portfolio is showing encouraging signs thanks to the simultaneous progress of the dollar and the market, despite remaining in the red. Strategic adjustments to the algorithm have been made to better manage currency risk, with a particular focus on stocks offering good resistance to dollar fluctuations.
Slightly better... Read More »
The portfolio's disappointing performance has prompted us to refocus on our investment strategy of regular dividends, while maintaining a long-term view. In the face of current market volatility and a weak dollar, it is crucial to maintain a realistic and disciplined approach, staying true to our objective of investing in quality stocks.
A dark week for defensives and the dollar Read More »
Discover our detailed analysis of Sanofi Aventis, the world's 5th largest pharmaceutical group, and its attractiveness as a dividend stock. The stock, trading at attractive prices with a yield of 5.16% in 2011, has attractive characteristics despite its relative youth compared to other major players in the sector.
Sanofi Aventis (PA:SAN) Read More »
The merger of Ciba-Geigy and Sandoz in 1996 gave rise to Novartis, now the world's 3rd largest pharmaceutical group. Despite its relative youth, the Basel-based company presents an attractive profile for investors, with a dividend yield of 3% and steadily increasing payouts.
Novartis (VTX:NOVN) Read More »
Français 
English 
Italiano 
Deutsch 
Español 
Português